News
8d
East Idaho News on MSNMajor insurance changes are coming to GLP-1 drugs for weight loss. Here’s how that could affect patientsTara Eacobacci had an appointment with her doctor that was devoted exclusively to the topic of health insurance. A major ...
12don MSN
Exclusive: Julie Bishop lost two-and-a-half stone in eight weeks by taking Mounjaro before she was sent to hospital with ...
MHRA says users of jabs such as Wegovy and Mounjaro reported inflamed pancreas - which can cause agonising abdominal pain - ...
Lizzo is cutting straight through the chatter about her recent weight loss. The 37-year-old star got real this week on the "Just Trish" podcast (June 19), opening up about how she's been ...
TUESDAY, June 24, 2025 (HealthDay News) — A new Chinese-developed GLP-1 weight loss drug could prove a new competitor to blockbuster drugs Ozempic /Wegovy and Zepbound, clinical trial results show.
On average, people in the 1.8 mg ecnoglutide group lost more than 13% of their body weight by week 48, and those in the 2.4 mg group lost more than 15%, researchers report.
Wellness influencer Janelle Rohner has seen the internet’s criticism after revealing she micro-dosed GLP-1 to lose weight. “‘Ozempic is cheating.’ ‘Ozempic is the easy way out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results